Literature DB >> 28813660

Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob.

Lisa K Denzin1, Aly A Khan2, Francesca Virdis1, Jessica Wilks3, Melissa Kane3, Helen A Beilinson3, Stanislav Dikiy3, Laure K Case3, Derry Roopenian4, Michele Witkowski1, Alexander V Chervonsky5, Tatyana V Golovkina6.   

Abstract

Select humans and animals control persistent viral infections via adaptive immune responses that include production of neutralizing antibodies. The precise genetic basis for the control remains enigmatic. Here, we report positional cloning of the gene responsible for production of retrovirus-neutralizing antibodies in mice of the I/LnJ strain. It encodes the beta subunit of the non-classical major histocompatibility complex class II (MHC-II)-like molecule H2-O, a negative regulator of antigen presentation. The recessive and functionally null I/LnJ H2-Ob allele supported the production of virus-neutralizing antibodies independently of the classical MHC haplotype. Subsequent bioinformatics and functional analyses of the human H2-Ob homolog, HLA-DOB, revealed both loss- and gain-of-function alleles, which could affect the ability of their carriers to control infections with human hepatitis B (HBV) and C (HCV) viruses. Thus, understanding of the previously unappreciated role of H2-O (HLA-DO) in immunity to infections may suggest new approaches in achieving neutralizing immunity to viruses.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HLA-DO; MHC locus; antigen presentation; neutralizing antibodies; positional cloning; viral infections

Mesh:

Substances:

Year:  2017        PMID: 28813660      PMCID: PMC5568092          DOI: 10.1016/j.immuni.2017.07.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  73 in total

1.  A novel class II MHC molecule with unusual tissue distribution.

Authors:  L Karlsson; C D Surh; J Sprent; P A Peterson
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

2.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

3.  HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport.

Authors:  M Liljedahl; T Kuwana; W P Fung-Leung; M R Jackson; P A Peterson; L Karlsson
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

Review 4.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

5.  Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.

Authors:  T V Radaeva; B V Nikonenko; V V Mischenko; M M Averbakh; A S Apt
Journal:  Tuberculosis (Edinb)       Date:  2004-12-31       Impact factor: 3.131

6.  Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses.

Authors:  T V Golovkina; I Piazzon; I Nepomnaschy; V Buggiano; M de Olano Vela; S R Ross
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection.

Authors:  Andrej Kosmrlj; Elizabeth L Read; Ying Qi; Todd M Allen; Marcus Altfeld; Steven G Deeks; Florencia Pereyra; Mary Carrington; Bruce D Walker; Arup K Chakraborty
Journal:  Nature       Date:  2010-05-05       Impact factor: 49.962

8.  Association of polymorphisms in HLA antigen presentation-related genes with the outcomes of HCV infection.

Authors:  Peng Huang; Yuanyuan Zhang; Xiaomei Lu; Yin Xu; Jie Wang; Yun Zhang; Rongbin Yu; Jing Su
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

9.  Antibody responses during hepatitis B viral infection.

Authors:  Stanca M Ciupe; Ruy M Ribeiro; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2014-07-31       Impact factor: 4.475

10.  Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.

Authors:  Jan M Pestka; Mirjam B Zeisel; Edith Bläser; Peter Schürmann; Birke Bartosch; Francois-Loïc Cosset; Arvind H Patel; Helga Meisel; Jens Baumert; Sergei Viazov; Kay Rispeter; Hubert E Blum; Michael Roggendorf; Thomas F Baumert
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-28       Impact factor: 11.205

View more
  22 in total

1.  Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation.

Authors:  Miguel Álvaro-Benito; Eliot Morrison; Friederike Ebner; Esam T Abualrous; Marie Urbicht; Marek Wieczorek; Christian Freund
Journal:  Cell Mol Immunol       Date:  2018-11-22       Impact factor: 11.530

2.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

3.  A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses.

Authors:  Melissa Kane; Felicity Deiss; Alexander Chervonsky; Tatyana V Golovkina
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

4.  Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of HLA-DOA That Have Altered Function.

Authors:  Austin M Graves; Francesca Virdis; Eliot Morrison; Miguel Álvaro-Benito; Aly A Khan; Christian Freund; Tatyana V Golovkina; Lisa K Denzin
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

Review 5.  What to do with HLA-DO/H-2O two decades later?

Authors:  Robin Welsh; Nianbin Song; Scheherazade Sadegh-Nasseri
Journal:  Immunogenetics       Date:  2019-01-26       Impact factor: 2.846

6.  MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naïve CD4+ T cells.

Authors:  Nadezhda N Logunova; Valeriia V Kriukova; Pavel V Shelyakin; Evgeny S Egorov; Alina Pereverzeva; Nina G Bozhanova; Mikhail Shugay; Dmitrii S Shcherbinin; Mikhail V Pogorelyy; Ekaterina M Merzlyak; Vasiliy N Zubov; Jens Meiler; Dmitriy M Chudakov; Alexander S Apt; Olga V Britanova
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-01       Impact factor: 11.205

7.  Genetic Control of Neonatal Immune Tolerance to an Exogenous Retrovirus.

Authors:  Emily Cullum; Stanislav Dikiy; Helen A Beilinson; Melissa Kane; Alessandra Veinbachs; Vera M Beilinson; Lisa K Denzin; Alexander Chervonsky; Tatyana Golovkina
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

Review 8.  The love and hate relationship of HLA-DM/DO in the selection of immunodominant epitopes.

Authors:  Robin A Welsh; Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2020-06-28       Impact factor: 7.486

9.  MHC Class II Presentation Is Affected by Polymorphism in the H2-Ob Gene and Additional Loci.

Authors:  Emily Cullum; Austin M Graves; Vera L Tarakanova; Lisa K Denzin; Tatyana Golovkina
Journal:  J Immunol       Date:  2021-06-16       Impact factor: 5.422

10.  Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation.

Authors:  Sushila A Toulmin; Chaitali Bhadiadra; Andrew J Paris; Jeffrey H Lin; Jeremy Katzen; Maria C Basil; Edward E Morrisey; G Scott Worthen; Laurence C Eisenlohr
Journal:  Nat Commun       Date:  2021-06-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.